Orchid Pharma Ltd.

BSE: 524372 | NSE: ORCHPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE191A01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Orchid Pharma Orchid Pharma Ltd. | BSE 810.75 21.45 (2.72%) | NSE 809.60 19.20 (2.43%) | Trade | Add

BSE Live

Nov 06, 13:10

810.75 21.45 (2.72%)

Volume

AVERAGE VOLUME

5-Day

10,189

10-Day

6,679

30-Day

5,345

10,762

Prev. Close

789.30
Open Price

794.95

Bid Price (Qty.)
808.05 (2)
Offer Price (Qty.)
810.10 (2)

NSE Live

Nov 06, 13:10

809.60 19.20 (2.43%)

Volume

AVERAGE VOLUME

5-Day

207,195

10-Day

127,779

30-Day

81,029

160,378

Prev. Close

790.40
Open Price

790.00

Bid Price (Qty.)
808.60 (15)
Offer Price (Qty.)
809.55 (4)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Orchid Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	921.93	816.11	656.66	556.85	449.60
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	921.93	816.11	656.66	556.85	449.60
Total Operating Revenues	921.93	819.37	665.90	559.56	450.06
Other Income	27.47	30.86	19.43	9.00	15.23
Total Revenue	949.40	850.23	685.33	568.56	465.29
EXPENSES
Cost Of Materials Consumed	585.46	528.35	406.10	340.62	245.60
Purchase Of Stock-In Trade	2.61	0.00	0.00	0.00	0.00
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-43.85	-43.89	-21.48	-27.06	-17.09
Employee Benefit Expenses	86.36	69.64	65.35	63.28	67.11
Finance Costs	14.54	16.35	32.23	32.01	51.34
Depreciation And Amortisation Expenses	34.55	33.24	54.79	87.02	108.92
Other Expenses	174.17	154.59	132.31	129.59	104.67
Total Expenses	853.84	758.29	669.29	625.46	560.54
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	95.56	91.95	16.04	-56.90	-95.25
Exceptional Items	0.00	0.00	39.21	0.00	0.00
Profit/Loss Before Tax	95.56	91.95	55.25	-56.90	-95.25
Tax Expenses-Continued Operations
Current Tax	0.00	0.11	0.00	0.00	0.00
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.10	-3.23	0.00	0.00	0.00
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-0.19	-3.12	0.00	0.00	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	95.76	95.06	55.25	-56.90	-95.25
Profit/Loss From Continuing Operations	95.76	95.06	55.25	-56.90	-95.25
Profit/Loss For The Period	95.76	95.06	48.47	1.57	-116.53
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	99.66	92.17	46.32	-1.95	-116.53
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	20.00	19.00	11.00	0.00	-29.00
Diluted EPS (Rs.)	20.00	19.00	11.00	0.00	-29.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00